Trials / Unknown
UnknownNCT05089942
Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021
Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021 in Healthy and Diabetic Patients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- Sponsor
- Zhejiang Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate the efficacy，safety， and tolerability of the recombinant human insulin patch ZJSRM2021 in healthy subjects, type 1diabetes mellitus and type 2diabetes mellitus patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Recombinant Human Insulin Patch ZJSRM2021 | health subjects receive recombinant human insulin patch ZJSRM2021，diabetic patients receive recombinant human insulin patch ZJSRM2021（low-dosage or high dosage） |
| DRUG | Placebo | health subjects receive placebo patch |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2021-12-01
- Completion
- 2022-12-01
- First posted
- 2021-10-22
- Last updated
- 2021-11-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05089942. Inclusion in this directory is not an endorsement.